Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is still poorly ...

The following is a summary of “Clinical Performance of Spo 2 /Fio 2 and Pao 2 /Fio 2 Ratio in Mechanically Ventilated Acute Respiratory Distress Syndrome Patients: A Retrospective Study,” published in ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The following is a summary of “Prognostic value of PaO2/FiO2 ratio in predicting clinical outcomes in COVID-19 patients,” published in the June 2024 issue of Critical Care by Canto-Costal et al.

The models use maximal deflection of esophageal pressure to quantify HFOT-related breathing effort (ΔPes) and the risk for strong breathing effort (ΔPes >10 cmH2O). Two models have been developed to ...

ABSTRACT: Importance: The best respiratory support technique to reduce intubation and mortality in patients with respiratory failure due to COVID-19 is controversial. Objective: To determine the ...

ABSTRACT: Background: Recombinant human soluble thrombomodulin (rhTM) was approved for the treatment of disseminated intravascular coagulation in Japan, and rhTM has anti-inflammatory effects.

The PF ratio (PaO2/FiO2 ratio) is an essential indicator used in medicine to gauge the severity of a patient’s hypoxemic respiratory failure. This value helps healthcare professionals determine ...

The P/F ratio, also known as the PaO2/FiO2 ratio, is a valuable tool for evaluating oxygenation status in critically ill patients. It is commonly used to determine the severity of acute respiratory ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The performance of prognostic models for COVID-19 is ...